Evidence map›Paper›PMID 33407816›Full record

ArticleJournal of biomedical semantics2021

An ontology-based approach for developing a harmonised data-validation tool for European cancer registration.

Nicholas Charles Nicholson, Francesco Giusti, Manola Bettio, Raquel Negrao Carvalho, Nadya Dimitrova, Tadeusz Dyba, Manuela Flego, Luciana Neamtiu, Giorgia Randi, Carmen Martos

Abstract read
In one paragraph

Article in Journal of biomedical semantics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. A multipurpose TNM stage ontology for cancer registries.Journal of biomedical semantics · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Nicholas Charles NicholsonEuropean Commission, Joint Research Centre, Via E. Fermi 2749, I-21027, Ispra, VA, Italy. nicholas.nicholson@ec.europa.eu.ORCID 0000-0003-1149-1426
Francesco GiustiEuropean Commission, Joint Research Centre, Via E. Fermi 2749, I-21027, Ispra, VA, Italy.
Manola BettioEuropean Commission, Joint Research Centre, Via E. Fermi 2749, I-21027, Ispra, VA, Italy.
Raquel Negrao CarvalhoEuropean Commission, Joint Research Centre, Via E. Fermi 2749, I-21027, Ispra, VA, Italy.
Nadya DimitrovaEuropean Commission, Joint Research Centre, Via E. Fermi 2749, I-21027, Ispra, VA, Italy.
Tadeusz DybaEuropean Commission, Joint Research Centre, Via E. Fermi 2749, I-21027, Ispra, VA, Italy.
Manuela FlegoEuropean Commission, Joint Research Centre, Via E. Fermi 2749, I-21027, Ispra, VA, Italy.
Luciana NeamtiuEuropean Commission, Joint Research Centre, Via E. Fermi 2749, I-21027, Ispra, VA, Italy.
Giorgia RandiEuropean Commission, Joint Research Centre, Via E. Fermi 2749, I-21027, Ispra, VA, Italy.
Carmen MartosEuropean Commission, Joint Research Centre, Via E. Fermi 2749, I-21027, Ispra, VA, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPopulation-based cancer registries constitute an important information source in cancer epidemiology. Studies collating and comparing data across regional and national boundaries have proved important for deploying and evaluating effective cancer-control strategies. A critical aspect in correctly comparing cancer indicators across regional and national boundaries lies in ensuring a good and harmonised level of data quality, which is a primary motivator for a centralised collection of pseudonymised data. The recent introduction of the European Union's general data-protection regulation (GDPR) imposes stricter conditions on the collection, processing, and sharing of personal data. It also considers pseudonymised data as personal data. The new regulation motivates the need to find solutions that allow a continuation of the smooth processes leading to harmonised European cancer-registry data. One element in this regard would be the availability of a data-validation software tool based on a formalised depiction of the harmonised data-validation rules, allowing an eventual devolution of the data-validation process to the local level.

resultsA semantic data model was derived from the data-validation rules for harmonising cancer-data variables at European level. The data model was encapsulated in an ontology developed using the Web-Ontology Language (OWL) with the data-model entities forming the main OWL classes. The data-validation rules were added as axioms in the ontology. The reasoning function of the resulting ontology demonstrated its ability to trap registry-coding errors and in some instances to be able to correct errors.

conclusionsDescribing the European cancer-registry core data set in terms of an OWL ontology affords a tool based on a formalised set of axioms for validating a cancer-registry's data set according to harmonised, supra-national rules. The fact that the data checks are inherently linked to the data model would lead to less maintenance overheads and also allow automatic versioning synchronisation, important for distributed data-quality checking processes.

Indexed as

NeoplasmsSoftwareHumansLanguageCancer registryData federationData harmonisationData validationOntologySemantic web

Identifiers

PMID33407816
PMCPMC7789225

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.